Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

about

Mechanisms of doxorubicin resistance in hepatocellular carcinoma IFI44L is a novel tumor suppressor in human hepatocellular carcinoma affecting cancer stemness, metastasis, and drug resistance via regulating met/Src signaling pathway.

P2860

Q36687760-F1AA55CF-8A5F-4464-B5C6-F04D883D95EE Q54966891-174DBB75-9CCD-4D73-AF13-665FB1A379CF

P2860

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

Item

http://www.wikidata.org/entity/Q53221564

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

@en

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

@nl

type

Item

label

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

@en

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

@nl

prefLabel

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

@en

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

@nl

P1476

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs

@en

P2093

Devis Pascut

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells

Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

MicroRNAs involved in neoplastic transformation of liver cancer stem cells.

The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study

Functional analysis of microRNAs in human hepatocellular cancer stem cells

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study.

miR-548c-5p inhibits proliferation and migration and promotes apoptosis in CD90(+) HepG2 cells.

MiR-181a-5p is downregulated in hepatocellular carcinoma and suppresses motility, invasion and branching-morphogenesis by directly targeting c-Met.

Clinical implications of microRNAs in liver cancer stem cells.

P304

723-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1586/17474124.2015.1041509

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Claudio Tiribelli

Beatrice Anfuso

Caecilia Hc Sukowati

P577

2015-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275662648

http://www.w3.org/2001/XMLSchema#string

P698

25920931

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

about

P2860

P2860

Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921